Login

Tag: name prominence

name prominence

Regulatory/FDA

FDA Finalizes Guidance on Name Placement, Size and Prominence

FDA Finalizes Guidance on Name Placement, Size and Prominence

Dec. 15, 2017 – The FDA announced this week that it has finalized its guidance document covering how industry should treat product name placement, size and prominence in promotional labeling and ads, largely keeping intact the draft guidance document it issued on the matter in 2013, and reiterating the agency’s position that “the disclosure of […]

Read more

Categories

Recent Posts

Tags

4A's ACA ad tax Advertising Coalition CDER chc CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media FTC gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication OPDP OPDP enforcement PhRMA regulation rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines